Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Eye drop capable of assisting treatment of conjunctivitis

A technology for adjuvant treatment and conjunctivitis, applied in the field of pharmaceutical chemicals, can solve problems such as inability to adjuvant treatment or relieve conjunctivitis

Inactive Publication Date: 2020-03-10
李达欣
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The purpose of the present invention is to solve the problem that traditional eye drops can only moisturize the eyes and cannot assist in the treatment or relief of conjunctivitis, and provide an eye drop that can assist in the treatment of conjunctivitis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] An eye drop capable of assisting the treatment of conjunctivitis, comprising the following components and weight ratios: 120% water, 60% isothiocyanate, 55% pranoprofen, 40% sodium nitrate, 30% citric acid, 28% sodium citrate, Potassium nitrate 26, disodium hydrogen phosphate 25, sodium sulfate 25, sodium hyaluronate 23, ethyl acetate 21, soybean lecithin 19, curcumin 16, polyphenol flavonoid 13, povidone 10, mannitol 8, glucose 6 , Benzalkonium chloride 3.

Embodiment 2

[0014] An eye drop capable of assisting the treatment of conjunctivitis, comprising the following components and weight ratios: water 115, isothiocyanate 58, pranoprofen 49, sodium nitrate 36, citric acid 28, sodium citrate 26, Potassium nitrate 25, disodium hydrogen phosphate 24, sodium sulfate 23, sodium hyaluronate 21, ethyl acetate 19, soybean lecithin 15-19, curcumin 15, polyphenol flavonoid 12, povidone 8, mannitol 7, Glucose 5, Gemini 2.

Embodiment 3

[0016] An eye drop capable of assisting the treatment of conjunctivitis, comprising the following components and weight ratios: water 100, isothiocyanate 50, pranoprofen 40, sodium nitrate 30, citric acid 20, sodium citrate 20, Potassium nitrate 20, disodium hydrogen phosphate, sodium sulfate 20, sodium hyaluronate 20-23, ethyl acetate 18, soybean lecithin 15, curcumin 13, polyphenol flavonoid 10, povidone 6, mannitol 6, glucose 3. Sorbitol 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an eye drop capable of assisting the treatment of conjunctivitis, and belongs to the field of pharmaceutical chemicals. The eye drop contains the following components in partsby weight: 100-120 parts of water, 50-60 parts of an isothiocyanate, 40-55 parts of pranoprofen, 30-40 parts of sodium nitrate, 20-30 parts of citric acid, 20-28 parts of sodium citrate, 20-26 parts of potassium nitrate, 20-25 parts of disodium hydrogen phosphate, 20-25 parts of sodium sulfate, 20-23 parts of sodium hyaluronate, 18-21 parts of ethyl acetate, 15-19 parts of soy phospholipid, 13-16parts of curcumin, 10-13 parts of a polyphenol flavonoid, 6-10 parts of povidone, 6-8 parts of mannitol, 3-6 parts of glucose, and 1-3 parts of a preservative. The eye drop solves the problem a traditional eye drops can only have a moisturizing effect on eyes and cannot assist in the treatment or relief of the conjunctivitis.

Description

technical field [0001] The invention relates to the field of pharmaceutical chemicals, in particular to an eye drop that can assist in the treatment of conjunctivitis. Background technique [0002] Corneal inflammation caused by various factors is collectively referred to as keratitis. It is one of the common diseases in ophthalmology, and it is also one of the main blinding eye diseases in my country. The cornea is located at the front of the eyeball and is in direct contact with the outside world. It is vulnerable to damage from microorganisms, trauma, and physical and chemical stimuli and inflammation. Clinically, it manifests as stimulating symptoms such as blurred vision, pain, photophobia and tearing, and obvious vision loss. Ophthalmic examination shows loss of corneal luster, decreased transparency, and ulceration. In severe cases, secondary corneal perforation, intraocular infection and even blindness may occur. At present, keratitis is divided into infectious, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/08A61K31/26A61K31/436A61K47/02A61K47/12A61K47/14A61K47/36A61K47/24A61K47/32A61K47/26A61K47/08A61P27/02
CPCA61K9/0048A61K9/08A61K31/26A61K31/436A61K47/02A61K47/08A61K47/12A61K47/14A61K47/24A61K47/26A61K47/32A61K47/36A61P27/02A61K2300/00
Inventor 李达欣
Owner 李达欣
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com